investors.oricpharma.com Open in urlscan Pro
2a02:26f0:1700:11::b856:679d Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
https://email.analystratings.net/ls/click?upn=u001.iYi-2FxQqc-2B6Z1nTxMHi5znQIygJKIrTlDaxCZ0IX72seVM4mEXasAtfOi0T9K-2B5jyxQpoAxH-...
Effective URL:
https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaboratio...
Submission: On November 18 via api (November 18th 2024, 5:39:26 am UTC) from BE — Scanned from DE

Summary HTTP 40 Redirects Links 27 Behaviour Indicators

Summary

This website contacted 9 IPs in 3 countries across 9 domains to perform 40 HTTP transactions. The main IP is 2a02:26f0:1700:11::b856:679d, located in Frankfurt am Main, Germany and belongs to AKAMAI-ASN1 Akamai International B.V., NL. The main domain is investors.oricpharma.com.
TLS certificate: Issued by R11 on October 31st 2024. Valid for: 3 months.

This is the only time investors.oricpharma.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 1	2606:4700:10:... 2606:4700:10::6816:296e	13335 (CLOUDFLAR...) (CLOUDFLARENET)
29	2a02:26f0:170... 2a02:26f0:1700:11::b856:679d	20940 (AKAMAI-AS...) (AKAMAI-ASN1 Akamai International B.V.)
1	2a02:26f0:b70... 2a02:26f0:b700:3::210:cc9d	20940 (AKAMAI-AS...) (AKAMAI-ASN1 Akamai International B.V.)
2	2a04:4e42::649 2a04:4e42::649	54113 (FASTLY) (FASTLY)
1	104.18.10.207 104.18.10.207	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	2a02:26f0:350... 2a02:26f0:3500:587::1e80	20940 (AKAMAI-AS...) (AKAMAI-ASN1 Akamai International B.V.)
1	2a00:1450:400... 2a00:1450:4001:812::200a	15169 (GOOGLE) (GOOGLE)
2	142.250.186.99 142.250.186.99	15169 (GOOGLE) (GOOGLE)
3	172.67.39.148 172.67.39.148	13335 (CLOUDFLAR...) (CLOUDFLARENET)
40	9

1 2606:4700:10::6816:296e (United States) 1 redirects

ASN13335 (CLOUDFLARENET, US)

email.analystratings.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

29 2a02:26f0:1700:11::b856:679d (Frankfurt am Main, Germany)

ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL)

investors.oricpharma.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a02:26f0:b700:3::210:cc9d (Hamburg, Germany)

ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL)

ml.globenewswire.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a04:4e42::649 (United States)

ASN54113 (FASTLY, US)

code.jquery.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.18.10.207 (None, )

ASN13335 (CLOUDFLARENET, US)

stackpath.bootstrapcdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a02:26f0:3500:587::1e80 (Frankfurt am Main, Germany)

ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL)

assets.adobedtm.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:812::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

fonts.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 142.250.186.99 (United States)

ASN15169 (GOOGLE, US)
PTR: fra24s06-in-f3.1e100.net

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 172.67.39.148 (United States)

ASN13335 (CLOUDFLARENET, US)

static.addtoany.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
29	oricpharma.com investors.oricpharma.com	1 MB
3	addtoany.com static.addtoany.com — Cisco Umbrella Rank: 4382	28 KB
2	gstatic.com fonts.gstatic.com	76 KB
2	jquery.com code.jquery.com — Cisco Umbrella Rank: 847	207 KB
1	googleapis.com fonts.googleapis.com — Cisco Umbrella Rank: 29	1 KB
1	adobedtm.com assets.adobedtm.com — Cisco Umbrella Rank: 458	50 KB
1	bootstrapcdn.com stackpath.bootstrapcdn.com — Cisco Umbrella Rank: 3370	17 KB
1	globenewswire.com ml.globenewswire.com — Cisco Umbrella Rank: 70080	269 B
1	analystratings.net 1 redirects email.analystratings.net — Cisco Umbrella Rank: 289291	804 B
40	9

	Domain	Requested by
29	investors.oricpharma.com	investors.oricpharma.com
3	static.addtoany.com	investors.oricpharma.com static.addtoany.com
2	fonts.gstatic.com	fonts.googleapis.com
2	code.jquery.com	investors.oricpharma.com
1	fonts.googleapis.com	investors.oricpharma.com
1	assets.adobedtm.com	investors.oricpharma.com
1	stackpath.bootstrapcdn.com	investors.oricpharma.com
1	ml.globenewswire.com	investors.oricpharma.com
1	email.analystratings.net	1 redirects
40	9

This site contains links to these domains. Also see Links.

Domain
oricpharma.com
dev.oricpharma.com
www.linkedin.com
www.globenewswire.com

Subject Issuer	Validity	Valid
leapfrog-ssl-27.gcs-web.com R11	`2024-10-31` - `2025-01-29`	3 months	crt.sh
ml.globenewswire.com E5	`2024-09-18` - `2024-12-17`	3 months	crt.sh
*.jquery.com Sectigo ECC Domain Validation Secure Server CA	`2024-06-25` - `2025-06-25`	a year	crt.sh
bootstrapcdn.com WE1	`2024-11-18` - `2025-02-16`	3 months	crt.sh
assets.adobedtm.com DigiCert Global G2 TLS RSA SHA256 2020 CA1	`2024-07-09` - `2025-08-09`	a year	crt.sh
upload.video.google.com WR2	`2024-10-21` - `2025-01-13`	3 months	crt.sh
*.gstatic.com WR2	`2024-10-21` - `2025-01-13`	3 months	crt.sh
static.addtoany.com WE1	`2024-11-03` - `2025-02-01`	3 months	crt.sh

This page contains 2 frames:

Primary Page: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick
Frame ID: C45AA1E4983F72158258DDAAAA157156
Requests: 41 HTTP requests in this frame

Frame: https://static.addtoany.com/menu/sm.25.html
Frame ID: CFDADEA8279E2C20FB730173FD942EB6
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Can

Page URL History Show full URLs

https://email.analystratings.net/ls/click?upn=u001.iYi-2FxQqc-2B6Z1nTxMHi5znQIygJKIrTlDaxCZ0IX72seVM4mEXasAtf... HTTP 302
https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-c... Page URL

Detected technologies

Bootstrap (Web Frameworks) Expand

Overall confidence: 100%
Detected patterns

bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

AddToAny (Widgets) Expand

Overall confidence: 100%
Detected patterns

addtoany\.com/menu/page\.js

Akamai Bot Manager (Security) Expand

Overall confidence: 100%
Detected patterns

DataTables (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

dataTables.*\.js

Font Awesome (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Modernizr (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

([\d.]+)?/modernizr(?:\.([\d.]+))?.*\.js

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery[.-]([\d.]*\d)[^/]*\.js
jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

jQuery UI (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

([\d.]+)/jquery-ui(?:\.min)?\.js
jquery-ui.*\.js

Page Statistics

40
Requests

100 %
HTTPS

67 %
IPv6

9
Domains

9
Subdomains

9
IPs

3
Countries

1481 kB
Transfer

4189 kB
Size

1
Cookies

27 Outgoing links

These are links going to different origins than the main page.

URL: https://oricpharma.com/
Title: OricPharma logo

Search URL Search Domain Scan URL

URL: https://oricpharma.com/about/
Title: About

Search URL Search Domain Scan URL

URL: https://oricpharma.com/about/#leadership
Title: Leadership Team

Search URL Search Domain Scan URL

URL: https://oricpharma.com/about/#board-directors
Title: Board of Directors

Search URL Search Domain Scan URL

URL: https://oricpharma.com/about/#founders
Title: Founders

Search URL Search Domain Scan URL

URL: https://oricpharma.com/about/#contact
Title: Contact

Search URL Search Domain Scan URL

URL: https://oricpharma.com/pipeline/
Title: Pipeline

Search URL Search Domain Scan URL

URL: https://oricpharma.com/pipeline/#oric533
Title: ORIC-533

Search URL Search Domain Scan URL

URL: https://oricpharma.com/pipeline/#oric114
Title: ORIC-114

Search URL Search Domain Scan URL

URL: https://oricpharma.com/pipeline/#oric944
Title: ORIC-944

Search URL Search Domain Scan URL

URL: https://oricpharma.com/pipeline/#plk4
Title: PLK4

Search URL Search Domain Scan URL

URL: https://oricpharma.com/publications/
Title: Publications

Search URL Search Domain Scan URL

URL: https://oricpharma.com/patients/
Title: Patients

Search URL Search Domain Scan URL

URL: https://oricpharma.com/patients/#trials
Title: Clinical Trials

Search URL Search Domain Scan URL

URL: http://dev.oricpharma.com/careers/
Title: Careers

Search URL Search Domain Scan URL

URL: https://oricpharma.com/careers/
Title: Overview

Search URL Search Domain Scan URL

URL: https://oricpharma.com/careers/#values
Title: Culture & Values

Search URL Search Domain Scan URL

URL: https://oricpharma.com/careers/#benefits
Title: Benefits

Search URL Search Domain Scan URL

URL: https://oricpharma.com/careers/#openings
Title: Current Openings

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/oric-pharmaceuticals-inc/?viewAsMember=true

Search URL Search Domain Scan URL

URL: https://www.globenewswire.com/Tracker?data=_d2f4VveDVDw7m3CTfy1bcMcn10vVeU-t6R0d7bFBGFyE1Tc_g7DJA7p4MAAk7kIHlc0Pa95bn6FoQvuXjXaCfqJTKuGF46hA3R6PhAax5wDei-jX7Fjw4f1sWsRJfLpWODcfI9fw-DkmyfmK_EXIAaafuQ7WxxulSDjmnptPSGVBiqb9Xe8R3p6ZvGJnb45114mV-BkIOZDzXf9MQQg1CzoBjXrWlEQG3-eLTKm4DQI22Qtfv6iuAsmzfvDp3GxUEyNKsurtRjKHhjhIRudQw==
Title: www.oricpharma.com

Search URL Search Domain Scan URL

URL: https://www.globenewswire.com/Tracker?data=wJ9fVGgSx6EoN8gLAYxF8eTmMJ0KUUcx2RBUxgUkHmdn9C6c1bUk1BccRFTzaN7-VYjKJq_ybQKh3BZ8KYHrBKqn_DA8AbOKk-lO4NGcjA-91lBAli_5Oh6uAXibQmLQ8iExTf29UjZQjX8-n4OVCuRxP3kfJLgkVbvAiP5WFCVqZbTmoj7k9-l6Hn6S3B4wR_ZzKG8HcPvRKZfnn4nNxA==
Title: X

Search URL Search Domain Scan URL

URL: https://www.globenewswire.com/Tracker?data=HirP_tflXEvMVA-31dyezJ4MfkAf-muej4bqtkzJWRgEbR_5qCVvRL-r9vr84cGGM1RRB3XaYUL3D-l38Hs_eUqM_4IT7LH-EE1Oqqt1C-6fGxl_4cAQGykA3X6wPMKBhj1vwdKon50Ewvx5Mx-zYg3QAHuuyqgi_VDLgtlG30XPFVJzNYXIxgwo6LRF6Gg_GTLBKAd6LmfdzJjrc6qnZwVVMN4v7shUt5Jv5gXPL5n79AsoGhig_jrlKK2ynMAFouCO0ox3VfcDwvHDdTS3KA==
Title: LinkedIn

Search URL Search Domain Scan URL

URL: https://www.globenewswire.com/Tracker?data=aERWxKI6aCEtpxp6lYHRVK5HuaFGZFrz3Gv6B5yCYNxEGRZpNi4pM_P1LTEctqScR0wveV4YPCOBuZkW6gR_Nc4By4BTW927qqTdt1uUfmknl0EfyQIJ_b-m4YE7S1Q7DZWCpbaZV9zRsgAGhyT1wg==
Title: dominic.piscitelli@oricpharma.com

Search URL Search Domain Scan URL

URL: https://www.globenewswire.com/Tracker?data=kLCIxq3sLCfRcwuHcX_jsquKMsDfLnM3oFx3JvLgFo1Q0EZIUsirp0q_cSfMGsiWvnrWGMV9BiQPKmOon-VvhuEKVSg8G4DF4RSA6-tNTOs=
Title: info@oricpharma.com

Search URL Search Domain Scan URL

URL: https://oricpharma.com/privacy-policy/
Title: Privacy Policy

Search URL Search Domain Scan URL

URL: https://oricpharma.com/terms-of-use/
Title: Terms of Use

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

https://email.analystratings.net/ls/click?upn=u001.iYi-2FxQqc-2B6Z1nTxMHi5znQIygJKIrTlDaxCZ0IX72seVM4mEXasAtfOi0T9K-2B5jyxQpoAxH-2BcBKMixFbkxo6XUONREoi31URC0BbPW3yK6aMi5dYALT3VnHM5rThF-2Bkn-2FCP7Sa2FMG1zfZi3A0iYjKJMwDR3joucpuJWFE18Z1WI1XPAsVzaOit1OH5BuSGUpQ1YruFb7WcosXMiuciBdYiN9eV1RxjoKl-2FL2QMyeUeVEV6H7gqfOi-2FY57qOUENZJfQ5H9br7okIr-2F3Y0FqupcQ3uZTZaGpiOtJpHo-2BoxYkw4M30nMpPCeLpP2FaT37rXfVzQp1FVgNcV66EwsH96ddrhOKiMwJs2lFjI9uG0qw4Nw5jnr2IkE0LILrrsXOLkHXc78kQnVZRFB8BO9BU4DrCFlAcCzQ5nkF2mgPWLr77QEh0m1zSoG-2BmHwrn36O5RIUu0W0wJMBeTWPesb5FNbgCA3t2EMtpPppqXEzdPIM-3DKofg_tUVFAbhJxF44ufbifaYzyYApcQooCC4WsuZoiwe419OhIOh3A-2BKWEzAXNcf3P6pwh9rtCgiVyjjMrs-2BwFqPjRiirlFqq6ZiEPwAJCnP1yGOBYTK-2BX1l89LGsn4JOC1l7eOK1lnXCdTxdrLWWNDkycy7T-2B99W4gDjlQFAixMSXLbxPioJpUyhU4360ANUS47yCxlcOcM4QJ8YuoK6lJO0e44ZlUKFOoOlSBKYsrNbxGPEeza4Mt21qqKPOl9pySWA HTTP 302
https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

40 HTTP transactions
2 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

200

Primary Request oric-pharmaceuticals-announces-multiple-clinical-collaborations Show response
investors.oricpharma.com/news-releases/news-release-details/
Redirect Chain

https://email.analystratings.net/ls/click?upn=u001.iYi-2FxQqc-2B6Z1nTxMHi5znQIygJKIrTlDaxCZ0IX72seVM4mEXasAtfOi0T9K-2B5jyxQpoAxH-2BcBKMixFbkxo6XUONREoi31URC0BbPW3yK6aMi5dYALT3VnHM5rThF-2Bkn-2FCP7Sa...
https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68...

39 KB
12 KB

579ms
432ms

Document
text/html

2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

5264c1b1a0919184ed6292af1d92ce7c66e8d8ef788012a7071f02f098b67723

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36

Response headers

accept-ranges: bytes
cache-control: public, max-age=0, s-maxage=2700
content-encoding: gzip
content-language: en
content-length: 10320
content-type: text/html; charset=UTF-8
date: Mon, 18 Nov 2024 05:39:21 GMT
etag: "1731908361"
expect-ct: max-age=0, report-uri="/report-expect-ct-violation"
expires: Mon, 18 Nov 2024 05:39:21 GMT
feature-policy: accelerometer 'none';ambient-light-sensor 'none';autoplay 'self';camera 'none';encrypted-media 'none';fullscreen 'self';geolocation 'self';gyroscope 'none';magnetometer 'none';microphone 'none';midi 'none';payment 'none';picture-in-picture 'none';speaker 'self';sync-xhr 'self';usb 'none';vibrate 'none';vr 'none'
from-origin: same
last-modified: Mon, 18 Nov 2024 05:39:21 GMT
referrer-policy: no-referrer-when-downgrade
strict-transport-security: max-age=31536000
vary: Accept-Encoding
x-age: 0
x-akamai-transformed: 9 10211 0 pmb=mTOE,2
x-content-type-options: nosniff
x-drupal-dynamic-cache: UNCACHEABLE
x-edgeconnect-midmile-rtt: 0 0 0
x-edgeconnect-origin-mex-latency: 362 362 362
x-frame-options: SAMEORIGIN
x-request-id: v-763d72ce-a56f-11ef-b1a1-5bb5829947ce
x-xss-protection: 1; mode=block

Redirect headers

cf-cache-status: DYNAMIC
cf-ray: 8e459e98c871db08-FRA
content-type: text/html; charset=utf-8
date: Mon, 18 Nov 2024 05:39:21 GMT
location: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick
server: cloudflare
x-robots-tag: noindex, nofollow

GET
H2 200 css_g5GJl1eM4h1mrBMAN-kbTorG5cRvhiOLH0BqngXYKpQ.css
investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/ 45 KB
8 KB 52ms
51ms Stylesheet
text/css 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_g5GJl1eM4h1mrBMAN-kbTorG5cRvhiOLH0BqngXYKpQ.css?delta=0&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Requested by

Host: investors.oricpharma.com
URL: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

3242a39a60ae61c68fb027c405267374a29a34ca2483031d1f87e6a65cec5d9f

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-697b0150-934a-11ef-87e0-d7ad7c50e01d
cache-control: max-age=546
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:27 GMT
accept-ranges: bytes
content-length: 7904
x-age: 303921
date: Mon, 18 Nov 2024 05:39:21 GMT
content-type: text/css
last-modified: Thu, 17 Oct 2024 23:42:44 GMT
x-cache-hits: 180
x-edgeconnect-midmile-rtt: 0, 9
x-edgeconnect-origin-mex-latency: 85, 85

GET
H2 200 css_8JCt1d-IQRHospAg5iZAeoznET3IzNmgtjMi4ukibM4.css
investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/ 388 KB
61 KB 57ms
57ms Stylesheet
text/css 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_8JCt1d-IQRHospAg5iZAeoznET3IzNmgtjMi4ukibM4.css?delta=1&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

143e0d65f3b35b3a8c69eee6e94dc27ce2b40ff39968f51f7e08b76b1de63b0c

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-193c4ddc-934c-11ef-ae78-4ba69024062a
cache-control: max-age=536
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:17 GMT
accept-ranges: bytes
content-length: 61687
x-age: 303197
date: Mon, 18 Nov 2024 05:39:21 GMT
content-type: text/css
last-modified: Thu, 17 Oct 2024 23:42:44 GMT
x-cache-hits: 176
x-edgeconnect-midmile-rtt: 0, 8
x-edgeconnect-origin-mex-latency: 87, 87

GET
H2 200 css_EDzg9gf0XWYIYX3L1U5apmKV_y8-efnlh0X_fm0_KTE.css
investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/ 127 KB
18 KB 104ms
104ms Stylesheet
text/css 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_EDzg9gf0XWYIYX3L1U5apmKV_y8-efnlh0X_fm0_KTE.css?delta=3&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

838b2343c4f8681230419b6df98ebe043a7579d83399fda652fcd51d652fbaaf

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-979a2018-934d-11ef-8b2d-63da2007d8f0
cache-control: max-age=493
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:47:34 GMT
accept-ranges: bytes
content-length: 18275
x-age: 364592
date: Mon, 18 Nov 2024 05:39:21 GMT
content-type: text/css
last-modified: Thu, 17 Oct 2024 23:42:44 GMT
x-cache-hits: 193
x-edgeconnect-midmile-rtt: 0, 0, 8
x-edgeconnect-origin-mex-latency: 115, 86, 115

GET
H2 200 modernizr.min.js Show response
investors.oricpharma.com/core/assets/vendor/modernizr/ 7 KB
3 KB 116ms
115ms Script
application/javascript 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/core/assets/vendor/modernizr/modernizr.min.js?v=3.11.7

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

939fe220ac3999512e38ecd5397d7334210c1568e7aec55eb6c6f4d1316c8353

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-ed0f015e-9e4b-11ef-a42f-6f73f0b868a6
cache-control: max-age=556
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:37 GMT
accept-ranges: bytes
content-length: 3090
x-age: 752344
date: Mon, 18 Nov 2024 05:39:21 GMT
content-type: application/javascript
last-modified: Thu, 10 Oct 2024 00:05:44 GMT
x-cache-hits: 865
x-edgeconnect-midmile-rtt: 0, 0, 7
x-edgeconnect-origin-mex-latency: 89, 88, 89

GET
H2 200 js_PXBnifQQKotKJcMi6nWrndoFbGUBcwiHVPnv6yvC6Hs.js Show response
investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/ 2 KB
1 KB 117ms
117ms Script
text/javascript 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/js_PXBnifQQKotKJcMi6nWrndoFbGUBcwiHVPnv6yvC6Hs.js?scope=header&delta=1&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

022299bc8a5367c7acc5529bd6fd8874f4803263dad42833514fce7cdfa19aa9

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-2fc86a8e-934e-11ef-af1d-079394fb3520
cache-control: max-age=556
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:37 GMT
accept-ranges: bytes
content-length: 824
x-age: 258377
date: Mon, 18 Nov 2024 05:39:21 GMT
content-type: text/javascript
last-modified: Thu, 17 Oct 2024 23:42:44 GMT
x-cache-hits: 146
x-edgeconnect-midmile-rtt: 0, 0, 6
x-edgeconnect-origin-mex-latency: 85, 89, 85

GET
H2 200 54feafc Show response
investors.oricpharma.com/akam/13/ 26 KB
9 KB 149ms
148ms Script
application/javascript 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL: https://investors.oricpharma.com/akam/13/54feafc
Requested by: Host: investors.oricpharma.com
URL: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),
Reverse DNS
Software: /
Resource Hash: 71ac5d07c268853b667dce3f9e8c85949a13c88edb6fe1c8327e5d0001262ab7

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

cache-control: max-age=21600
content-encoding: gzip
etag: "1b57b8520fb3bee7ac4cffd94607d0b30f1346163d64855202a8f4bbd18fbc4d"
pragma: no-cache
expires: Mon, 18 Nov 2024 05:39:22 GMT
content-length: 8782
date: Mon, 18 Nov 2024 05:39:22 GMT
stored-attribute-sha-checksum: 71ac5d07c268853b667dce3f9e8c85949a13c88edb6fe1c8327e5d0001262ab7
last-modified: Thu, 22 Feb 2024 19:50:13 GMT
content-type: application/javascript
vary: Accept-Encoding

GET
H2 200 oric.png
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 34 KB
34 KB 119ms
119ms Image
image/png 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/oric.png

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

b7c244a4b0e62a2ca981f44af42a9d6c91bb1fa58586810fe24c0aab6fe44efe

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

x-request-id: v-da3f59ce-9e51-11ef-9a4e-b32c9e2441b3
cache-control: max-age=537
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:18 GMT
accept-ranges: bytes
content-length: 34750
x-age: 543461
date: Mon, 18 Nov 2024 05:39:21 GMT
content-type: image/png
last-modified: Thu, 10 Oct 2024 00:07:23 GMT
x-cache-hits: 655
x-edgeconnect-midmile-rtt: 0, 0, 4
x-edgeconnect-origin-mex-latency: 262, 262, 262

GET
H2 200 oric2.png
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 34 KB
34 KB 132ms
131ms Image
image/png 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/oric2.png

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

611a6bab4ed69471824f8f2592ac89a2021103bae52a35253c6e09233b2c6e35

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

x-request-id: v-ecee57ca-9e4f-11ef-813a-17cf510548fc
cache-control: max-age=532
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:13 GMT
accept-ranges: bytes
content-length: 34304
x-age: 779904
date: Mon, 18 Nov 2024 05:39:21 GMT
content-type: image/png
last-modified: Thu, 10 Oct 2024 00:05:59 GMT
x-cache-hits: 874
x-edgeconnect-midmile-rtt: 0, 0, 3
x-edgeconnect-origin-mex-latency: 171, 90, 171

GET
H2 200 empty.png
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 2 KB
3 KB 46ms
46ms Image
image/png 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/empty.png

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

c2427fd8b9f21f0a1f5e72e723ddff2b3f7960058c60d46d8c01736c1d190161

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

x-request-id: v-cc09855a-934d-11ef-b6e0-7743a0197775
cache-control: max-age=536
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:18 GMT
accept-ranges: bytes
content-length: 2540
x-age: 115641
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/png
last-modified: Thu, 10 Oct 2024 00:07:23 GMT
x-cache-hits: 92
x-edgeconnect-midmile-rtt: 0, 0, 4
x-edgeconnect-origin-mex-latency: 97, 85, 88

GET
H2 200 ORIC-Pharmaceuticals.png
ml.globenewswire.com/media/Zjk5MjdmMGUtMjJlMi00OTg1LWIxMDEtYTdkYTQ3NWFmNjE1LTEwOTI0NTY=/tiny/ 35 B
269 B 385ms
228ms Image
image/png 2a02:26f0:b700:3::210:cc9d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://ml.globenewswire.com/media/Zjk5MjdmMGUtMjJlMi00OTg1LWIxMDEtYTdkYTQ3NWFmNjE1LTEwOTI0NTY=/tiny/ORIC-Pharmaceuticals.png

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:b700:3::210:cc9d Hamburg, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Frame-Options	ALLOWALL
X-Xss-Protection	1; mode=block

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

strict-transport-security: max-age=31536000; includeSubDomains; preload
cache-control: no-cache, no-store, must-revalidate
pragma: no-cache
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:39:22 GMT
content-length: 35
x-xss-protection: 1; mode=block
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/png
x-frame-options: ALLOWALL

GET
H2 200 ico-print.svg
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 1 KB
967 B 47ms
47ms Image
image/svg+xml 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ico-print.svg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

4d6f6fa0a32e19a1c8fc9e9415bfaaac3554eccfb9c83dd8b54d2fd5aae213c5

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-32c4b20a-934f-11ef-8222-678602d61451
cache-control: max-age=549
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:31 GMT
accept-ranges: bytes
content-length: 571
x-age: 1008031
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/svg+xml
last-modified: Thu, 10 Oct 2024 00:07:23 GMT
x-cache-hits: 967
x-edgeconnect-midmile-rtt: 0, 0, 21
x-edgeconnect-origin-mex-latency: 114, 114, 88

GET
H2 200 ico-emailPage.svg
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 934 B
964 B 146ms
144ms Image
image/svg+xml 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ico-emailPage.svg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

12fcd37d1000275e573ddf683e214d16661357a8c36ca0ff45dc349629b6b30e

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-7b141742-8848-11ef-a1a2-a7a83ad891c7
cache-control: max-age=519
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:01 GMT
accept-ranges: bytes
content-length: 567
x-age: 1010701
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/svg+xml
last-modified: Thu, 10 Oct 2024 00:07:23 GMT
x-cache-hits: 1068
x-edgeconnect-midmile-rtt: 0, 0, 21
x-edgeconnect-origin-mex-latency: 456, 115, 90

GET
H2 200 ico-contactIR.svg
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 701 B
912 B 146ms
144ms Image
image/svg+xml 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ico-contactIR.svg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

4f7fc641a225fff76ef3b4d1ba3fdd12313e81f5820a94aaed71f38e9de331f9

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-bf5d1ce2-9e4a-11ef-9fd9-5b9c7c031c58
cache-control: max-age=445
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:46:47 GMT
accept-ranges: bytes
content-length: 465
x-age: 668046
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/svg+xml
last-modified: Thu, 10 Oct 2024 00:07:23 GMT
x-cache-hits: 715
x-edgeconnect-midmile-rtt: 0, 0, 0, 21
x-edgeconnect-origin-mex-latency: 87, 87, 87, 87

GET
H2 200 ico-rss.svg
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 1 KB
1 KB 146ms
145ms Image
image/svg+xml 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ico-rss.svg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

4c7f9b9700549e0a443d6651062f759fc0743568e0ce58b46306dac9abedb0c4

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-9e8fbf38-884c-11ef-be94-535b496b7d9d
cache-control: max-age=555
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:37 GMT
accept-ranges: bytes
content-length: 630
x-age: 1012339
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/svg+xml
last-modified: Thu, 10 Oct 2024 00:07:23 GMT
x-cache-hits: 1036
x-edgeconnect-midmile-rtt: 0, 0, 21
x-edgeconnect-origin-mex-latency: 339, 114, 87

GET
H2 200 ico-emailAlerts.svg
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 1 KB
1 KB 146ms
145ms Image
image/svg+xml 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ico-emailAlerts.svg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

88b2eb327407a60a793429c188b5d6b33188c2937a6cefa14bb141673594b963

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-697e4fa4-934a-11ef-a35b-9363426b9186
cache-control: max-age=548
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:30 GMT
accept-ranges: bytes
content-length: 732
x-age: 1012613
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/svg+xml
last-modified: Wed, 09 Oct 2024 13:03:00 GMT
x-cache-hits: 1046
x-edgeconnect-midmile-rtt: 0, 2, 13
x-edgeconnect-origin-mex-latency: 453, 115, 85

GET
H2 200 js_-tk32G3nIbO-HNzMIZv-bDy5SM8SDQ8M63MB0FlU_yA.js Show response
investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/ 109 KB
38 KB 45ms
45ms Script
text/javascript 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/js_-tk32G3nIbO-HNzMIZv-bDy5SM8SDQ8M63MB0FlU_yA.js?scope=footer&delta=0&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

642a76ea4d82920a6612f467308daff3ed90bc491f86371eb542641192558336

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-e8d03574-9363-11ef-96e0-57bfab278577
cache-control: max-age=438
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:46:40 GMT
accept-ranges: bytes
content-length: 38188
x-age: 249047
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: text/javascript
last-modified: Thu, 17 Oct 2024 23:42:45 GMT
x-cache-hits: 140
x-edgeconnect-midmile-rtt: 0, 1, 0, 20
x-edgeconnect-origin-mex-latency: 92, 92, 89, 92

GET
H2 200 jquery-1.12.4.js Show response
code.jquery.com/ 287 KB
85 KB 124ms
39ms Script
application/javascript 2a04:4e42::649
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://code.jquery.com/jquery-1.12.4.js
Requested by: Host: investors.oricpharma.com
URL: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a04:4e42::649 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 430f36f9b5f21aae8cc9dca6a81c4d3d84da5175eaedcf2fdc2c226302cb3575

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

content-encoding: gzip
etag: W/"28feccc0-47a36"
age: 1889367
x-cache: HIT, HIT
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: application/javascript; charset=utf-8
vary: Accept-Encoding
x-cache-hits: 3, 15802
last-modified: Fri, 18 Oct 1991 12:00:00 GMT
x-served-by: cache-lga21970-LGA, cache-cph2320058-CPH
cache-control: public, max-age=31536000, stale-while-revalidate=604800
x-timer: S1731908362.263134,VS0,VE0
via: 1.1 varnish, 1.1 varnish
accept-ranges: bytes
access-control-allow-origin: *
content-length: 87176
server: nginx

GET
H2 200 jquery-ui.js Show response
code.jquery.com/ui/1.12.1/ 509 KB
122 KB 124ms
39ms Script
application/javascript 2a04:4e42::649
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://code.jquery.com/ui/1.12.1/jquery-ui.js
Requested by: Host: investors.oricpharma.com
URL: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a04:4e42::649 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software: nginx /
Resource Hash: 4f455eb2ddf2094ee969f470f6bfac7adb4c057e8990a374e9da819e943c777d

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

content-encoding: gzip
etag: W/"28feccc0-7f20a"
age: 2298036
x-cache: HIT, HIT
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: application/javascript; charset=utf-8
vary: Accept-Encoding
x-cache-hits: 294, 37730
last-modified: Fri, 18 Oct 1991 12:00:00 GMT
x-served-by: cache-lga21932-LGA, cache-cph2320058-CPH
cache-control: public, max-age=31536000, stale-while-revalidate=604800
x-timer: S1731908362.263215,VS0,VE0
via: 1.1 varnish, 1.1 varnish
accept-ranges: bytes
access-control-allow-origin: *
content-length: 124434
server: nginx

GET
H2 200 js_UUx8Yq9sCfv_PaPx4x_bEazHLGIMAX9deoZWmyEA-OE.js Show response
investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/ 227 KB
70 KB 47ms
45ms Script
text/javascript 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/js_UUx8Yq9sCfv_PaPx4x_bEazHLGIMAX9deoZWmyEA-OE.js?scope=footer&delta=3&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

f21bdade54d50ba49de2f0fb872646911bd55d9e614d6dc02389c7042c96f851

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-b33c5fce-9353-11ef-b9a4-fb555ead0bd8
cache-control: max-age=539
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:21 GMT
accept-ranges: bytes
content-length: 71395
x-age: 182039
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: text/javascript
last-modified: Thu, 17 Oct 2024 23:42:44 GMT
x-cache-hits: 93
x-edgeconnect-midmile-rtt: 0, 0, 18
x-edgeconnect-origin-mex-latency: 88, 88, 88

GET
H2 200 ckeditor5-dll.js Show response
investors.oricpharma.com/core/assets/vendor/ckeditor5/ckeditor5-dll/ 745 KB
185 KB 60ms
58ms Script
application/javascript 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/core/assets/vendor/ckeditor5/ckeditor5-dll/ckeditor5-dll.js?v=40.2.0

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

dbf6d86ed58da33f90217f167e9afd12f71c44afe9aa514d8f0aa1499de7396a

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-bf71522a-9e4a-11ef-8d56-4fee0c8b2bc7
cache-control: max-age=499
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:47:41 GMT
accept-ranges: bytes
content-length: 189178
x-age: 782128
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: application/javascript
last-modified: Thu, 10 Oct 2024 00:05:44 GMT
x-cache-hits: 837
x-edgeconnect-midmile-rtt: 0, 17
x-edgeconnect-origin-mex-latency: 171, 171

GET
H2 200 datatables.js Show response
investors.oricpharma.com/profiles/nasdaqir/modules/custom/nir_ckeditor_datatables/js/build/ 392 KB
110 KB 142ms
140ms Script
application/javascript 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/profiles/nasdaqir/modules/custom/nir_ckeditor_datatables/js/build/datatables.js?v=1.10.9

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

2aaf0a1ecd155ee00ce4f973bd3874c304aad63a403ffd779c84df1eee8be461

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-3722d790-9e4f-11ef-8977-bbf880659ef5
cache-control: max-age=483
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:47:25 GMT
accept-ranges: bytes
content-length: 112179
x-age: 658558
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: application/javascript
last-modified: Thu, 10 Oct 2024 00:05:46 GMT
x-cache-hits: 734
x-edgeconnect-midmile-rtt: 0, 0, 15
x-edgeconnect-origin-mex-latency: 271, 87, 271

GET
H2 200 js_jdE2KAgQ6X5r0YOZhHIQNib9c1pcUCP2X4jW5TYuwzQ.js Show response
investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/ 366 KB
92 KB 142ms
140ms Script
text/javascript 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/js_jdE2KAgQ6X5r0YOZhHIQNib9c1pcUCP2X4jW5TYuwzQ.js?scope=footer&delta=6&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

2b4c8c43a52f706e40bc8b247e4a11456fbaaafeafb0a408e6d86d808d1cc4fe

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-725ffdac-934f-11ef-a313-af3fd28ee424
cache-control: max-age=555
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:37 GMT
accept-ranges: bytes
content-length: 94210
x-age: 183866
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: text/javascript
last-modified: Thu, 17 Oct 2024 23:42:46 GMT
x-cache-hits: 118
x-edgeconnect-midmile-rtt: 0, 0, 13
x-edgeconnect-origin-mex-latency: 85, 88, 85

GET
H3 200 bootstrap.min.js Show response
stackpath.bootstrapcdn.com/bootstrap/4.5.2/js/ 59 KB
17 KB 93ms
45ms Script
application/javascript 104.18.10.207
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://stackpath.bootstrapcdn.com/bootstrap/4.5.2/js/bootstrap.min.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

104.18.10.207 -, , ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

79c599dd760cec0c1621a1af49d9a2a49da5d45e1b37d4575bace0a5e0226582

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

cdn-status: 200
content-encoding: br
cf-cache-status: HIT
etag: W/"02d223393e00c273efdcb1ade8f4f8b1"
age: 1966270
x-content-type-options: nosniff
alt-svc: h3=":443"; ma=86400
server-timing: cfExtPri
date: Mon, 18 Nov 2024 05:39:22 GMT
last-modified: Mon, 25 Jan 2021 22:04:11 GMT
content-type: application/javascript; charset=utf-8
vary: Accept-Encoding
cdn-cache: HIT
cdn-cachedat: 03/25/2024 22:48:44
cdn-requestpullcode: 200
priority: u=2,i=?0
strict-transport-security: max-age=31536000; includeSubDomains; preload
cache-control: public, max-age=31919000
cdn-requestpullsuccess: True
timing-allow-origin: *
cdn-requesttime: 0
cdn-uid: b1941f61-b576-4f40-80de-5677acb38f74
cdn-requestid: f8e3843c33eb4c84bd4fd72a4bb6e02c
cross-origin-resource-policy: cross-origin
cdn-pullzone: 252412
cdn-proxyver: 1.04
cf-ray: 8e459e9fedfee51b-TXL
access-control-allow-origin: *
cdn-edgestorageid: 1053
server: cloudflare
cdn-requestcountrycode: DE

GET
H2 200 js_zPsXnQuI-4vZjoK1w3iZIqX5P0jyaMg96YaJm4eiWdg.js Show response
investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/ 10 KB
3 KB 144ms
143ms Script
text/javascript 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/js_zPsXnQuI-4vZjoK1w3iZIqX5P0jyaMg96YaJm4eiWdg.js?scope=footer&delta=8&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

5c187131f685db8c505ae2a330d10d1675bc8b8425122dd9fbaef956c507f808

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-697d5a04-934a-11ef-8e69-171f5cfd39f0
cache-control: max-age=543
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:25 GMT
accept-ranges: bytes
content-length: 2911
x-age: 303921
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: text/javascript
last-modified: Fri, 18 Oct 2024 05:34:52 GMT
x-cache-hits: 193
x-edgeconnect-midmile-rtt: 0, 11
x-edgeconnect-origin-mex-latency: 94, 94

GET
H2 200 launch-5ef258dce664.min.js Show response
assets.adobedtm.com/898335afd880/c52ee8aa1e90/ 163 KB
50 KB 157ms
38ms Script
application/x-javascript 2a02:26f0:3500:587::1e80
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:3500:587::1e80 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

AkamaiNetStorage /

Resource Hash

3777c25911c0259e059287354a170a0046dabc074b075d6e5ff47045f7a51492

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

cache-control: max-age=3600
timing-allow-origin: *
content-encoding: gzip
etag: "48246fd3c5f42a4da830ac25312a135f:1675447237.500488"
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 06:39:22 GMT
accept-ranges: bytes
access-control-allow-origin: https://investors.oricpharma.com
content-length: 50604
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: application/x-javascript
last-modified: Fri, 03 Feb 2023 18:00:37 GMT
server: AkamaiNetStorage
vary: Accept-Encoding

GET
H2 200 css_fRFgMHvUIrwF8Vol_D2EvhdWjI4QNCzRgkH6k-lkEZ0.css
investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/ 73 B
480 B 146ms
145ms Stylesheet
text/css 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_fRFgMHvUIrwF8Vol_D2EvhdWjI4QNCzRgkH6k-lkEZ0.css?delta=2&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

09a2967af142f102a1577e8a0831940b3e47101254b9649ee4f64bce68dcf326

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

vary: Accept-Encoding
x-request-id: v-d1b18a0c-934d-11ef-8a23-2f623b77cc72
cache-control: max-age=555
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:37 GMT
accept-ranges: bytes
content-length: 89
x-age: 258534
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: text/css
last-modified: Thu, 17 Oct 2024 23:42:44 GMT
x-cache-hits: 145
x-edgeconnect-midmile-rtt: 0, 0, 10
x-edgeconnect-origin-mex-latency: 89, 89, 89

GET
H2 200 css
fonts.googleapis.com/ 17 KB
1 KB 131ms
48ms Stylesheet
text/css 2a00:1450:4001:812::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Montserrat:300,300i,400,400i,500,500i,600,600i,700,700i

Requested by

Host: investors.oricpharma.com
URL: https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_8JCt1d-IQRHospAg5iZAeoznET3IzNmgtjMi4ukibM4.css?delta=1&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:812::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

96acd243fb67175371afbc6e621522128c11cdb95a15d7d707b4ec2c3d84e2cc

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_8JCt1d-IQRHospAg5iZAeoznET3IzNmgtjMi4ukibM4.css?delta=1&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Response headers

content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:39:22 GMT
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: text/css; charset=utf-8
vary: Sec-Fetch-Dest, Sec-Fetch-Mode, Sec-Fetch-Site
last-modified: Mon, 18 Nov 2024 05:30:18 GMT
x-frame-options: SAMEORIGIN
strict-transport-security: max-age=31536000
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
cross-origin-opener-policy: same-origin-allow-popups
cross-origin-resource-policy: cross-origin
access-control-allow-origin: *
x-xss-protection: 0
server: ESF

GET
H3 200 JTUSjIg1_i6t8kCHKm459Wlhyw.woff2
fonts.gstatic.com/s/montserrat/v29/ 37 KB
37 KB 94ms
40ms Font
font/woff2 142.250.186.99
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/montserrat/v29/JTUSjIg1_i6t8kCHKm459Wlhyw.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Montserrat:300,300i,400,400i,500,500i,600,600i,700,700i

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.186.99 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra24s06-in-f3.1e100.net

Software

sffe /

Resource Hash

fdc9964050bfa24c27a3c76c6791b3674292a5f352cbc83d7a4dc49595bc3fb1

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Origin: https://investors.oricpharma.com
Referer: https://fonts.googleapis.com/

Response headers

age: 353581
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
x-content-type-options: nosniff
expires: Fri, 14 Nov 2025 03:26:21 GMT
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date: Thu, 14 Nov 2024 03:26:21 GMT
last-modified: Wed, 06 Nov 2024 17:30:37 GMT
content-type: font/woff2
cache-control: public, max-age=31536000
timing-allow-origin: *
cross-origin-opener-policy: same-origin; report-to="apps-themes"
cross-origin-resource-policy: cross-origin
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
accept-ranges: bytes
access-control-allow-origin: *
content-length: 37828
x-xss-protection: 0
server: sffe

GET
H2 200 investors-scaled.jpg
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 89 KB
89 KB 123ms
122ms Image
image/jpeg 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/investors-scaled.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

e26db4d8e59af5f5c5fb727a2c2bac393b535aad8074be984c1e2e6516dd455f

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

x-request-id: v-c21a6198-9e94-11ef-8d08-f33bf48c6505
cache-control: max-age=556
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:38 GMT
accept-ranges: bytes
content-length: 90643
x-age: 355375
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/jpeg
last-modified: Thu, 10 Oct 2024 00:05:59 GMT
x-cache-hits: 132
x-edgeconnect-midmile-rtt: 0
x-edgeconnect-origin-mex-latency: 84

GET
H2 200 ico-oric.png
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ 181 KB
181 KB 75ms
74ms Image
image/png 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/images/ico-oric.png

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

65f44ffe733bbf9871a7bdd8c430d2b581215f5383fc3ee070ed0f69e41a9da8

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_8JCt1d-IQRHospAg5iZAeoznET3IzNmgtjMi4ukibM4.css?delta=1&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Response headers

x-request-id: v-fe260abc-9e7f-11ef-a243-97e5378858bf
cache-control: max-age=22
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:39:44 GMT
accept-ranges: bytes
content-length: 185117
x-age: 362385
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/png
last-modified: Thu, 10 Oct 2024 00:05:59 GMT
x-cache-hits: 131
x-edgeconnect-midmile-rtt: 5, 5
x-edgeconnect-origin-mex-latency: 143, 143

GET
H2 200 fontawesome-webfont.woff2
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/fonts/ 75 KB
76 KB 103ms
102ms Font
text/plain 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/client/fonts/fontawesome-webfont.woff2?v=4.7.0

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

42736c7de60dfab94b3cc902b8692f80cfeb0a5989d1d51db1d25fd7d18dc45b

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Origin: https://investors.oricpharma.com
Referer: https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_8JCt1d-IQRHospAg5iZAeoznET3IzNmgtjMi4ukibM4.css?delta=1&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Response headers

x-request-id: v-68c60d04-9e5d-11ef-be38-c37caea8d25d
cache-control: max-age=102
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:41:04 GMT
accept-ranges: bytes
content-length: 77160
x-age: 388118
date: Mon, 18 Nov 2024 05:39:22 GMT
last-modified: Thu, 10 Oct 2024 00:05:59 GMT
x-cache-hits: 157
x-edgeconnect-midmile-rtt: 0
x-edgeconnect-origin-mex-latency: 89

GET
H2 200 ndqfonticons.woff
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/fonts/ 33 KB
34 KB 109ms
109ms Font
text/plain 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/fonts/ndqfonticons.woff

Requested by

Host: investors.oricpharma.com
URL: https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_EDzg9gf0XWYIYX3L1U5apmKV_y8-efnlh0X_fm0_KTE.css?delta=3&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

976d22490288a04d5bc7edaa827b729f8d7df858b1df77b1aed89675eb2539ca

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Origin: https://investors.oricpharma.com
Referer: https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_EDzg9gf0XWYIYX3L1U5apmKV_y8-efnlh0X_fm0_KTE.css?delta=3&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Response headers

x-request-id: v-485ba8ba-9e78-11ef-a01e-2b0766e1c5ae
cache-control: max-age=470
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:47:12 GMT
accept-ranges: bytes
content-length: 34147
x-age: 765826
date: Mon, 18 Nov 2024 05:39:22 GMT
last-modified: Wed, 09 Oct 2024 13:01:40 GMT
x-cache-hits: 275
x-edgeconnect-midmile-rtt: 0, 0
x-edgeconnect-origin-mex-latency: 89, 89

GET
H3 200 JTUQjIg1_i6t8kCHKm459WxRyS7m.woff2
fonts.gstatic.com/s/montserrat/v29/ 39 KB
39 KB 83ms
44ms Font
font/woff2 142.250.186.99
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/montserrat/v29/JTUQjIg1_i6t8kCHKm459WxRyS7m.woff2

Requested by

Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Montserrat:300,300i,400,400i,500,500i,600,600i,700,700i

Protocol

Security

QUIC, , AES_128_GCM

Server

142.250.186.99 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra24s06-in-f3.1e100.net

Software

sffe /

Resource Hash

96a874a36a161a53381e9c5b16dcc188a04da68d463130aaf505c0f08de38782

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Origin: https://investors.oricpharma.com
Referer: https://fonts.googleapis.com/

Response headers

age: 325285
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
x-content-type-options: nosniff
expires: Fri, 14 Nov 2025 11:17:57 GMT
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date: Thu, 14 Nov 2024 11:17:57 GMT
last-modified: Wed, 06 Nov 2024 17:30:50 GMT
content-type: font/woff2
cache-control: public, max-age=31536000
timing-allow-origin: *
cross-origin-opener-policy: same-origin; report-to="apps-themes"
cross-origin-resource-policy: cross-origin
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
accept-ranges: bytes
access-control-allow-origin: *
content-length: 39608
x-xss-protection: 0
server: sffe

GET
H2 200 ndqfonticons.ttf
investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/fonts/ 63 KB
32 KB 44ms
44ms Font
text/plain 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/fonts/ndqfonticons.ttf

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

16b93dd817d794e50af67f1dd4739ba9e23ccb85054fe5e6d7dd7a7e9e7307eb

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Origin: https://investors.oricpharma.com
Referer: https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/css/css_EDzg9gf0XWYIYX3L1U5apmKV_y8-efnlh0X_fm0_KTE.css?delta=3&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Response headers

x-request-id: v-373745b0-9e5c-11ef-a9b4-8b9bdc2d0f18
cache-control: max-age=556
content-encoding: gzip
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:38 GMT
accept-ranges: bytes
content-length: 31720
x-age: 565716
date: Mon, 18 Nov 2024 05:39:22 GMT
last-modified: Thu, 10 Oct 2024 00:07:23 GMT
vary: Accept-Encoding
x-cache-hits: 190
x-edgeconnect-midmile-rtt: 0, 0
x-edgeconnect-origin-mex-latency: 87, 87

GET
H3 200 page.js Show response
static.addtoany.com/menu/ 3 KB
2 KB 93ms
44ms Script
application/javascript 172.67.39.148
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://static.addtoany.com/menu/page.js

Requested by

Host: investors.oricpharma.com
URL: https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/js_zPsXnQuI-4vZjoK1w3iZIqX5P0jyaMg96YaJm4eiWdg.js?scope=footer&delta=8&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8

Protocol

Security

QUIC, , AES_128_GCM

Server

172.67.39.148 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

fa2c31f1139ecdb4a5ee194df5b10f4844435639cdf791bebae6c49ee5b05089

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

content-encoding: br
cf-cache-status: HIT
etag: W/"7980d9a797beb21fbeb086d8f294ad7b"
age: 7556
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=0yT3gPvwMLy5vISY3R2aMaiNuTiFv4aQ6ISfav5z5GalFkbkCwkxXg0yDWk6EISm8UDRIo7Q90nSL9L4j0RA4ZPVOi9GOW5VZZKbuvxT6cka3lN4NFyEAWwD%2F8VnAt6tnGXn6Mg7CWsVONcXqGEH%2B7Ie"}],"group":"cf-nel","max_age":604800}
x-content-type-options: nosniff
alt-svc: h3=":443"; ma=86400
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: application/javascript
vary: Accept-Encoding
strict-transport-security: max-age=31536000; includeSubDomains; preload
cache-control: max-age=86400, stale-while-revalidate=30, public
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
speculation-rules: "/cdn-cgi/speculation"
referrer-policy: strict-origin-when-cross-origin
cf-ray: 8e459ea1e94fe519-TXL
access-control-allow-origin: *
server: cloudflare

GET
DATA 200
OK truncated
/ 9 KB
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: d554361630709572f4c9e33d02ca5ae56275756099a62195513017a0421f73c2

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer

Response headers

Content-Type: image/png

GET
DATA 200
OK truncated
/ 157 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 80d54533f80e8233621f965ae0a7713928bdb4d491ed0eb5e90434550f1894cb

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer

Response headers

Content-Type: image/png

GET
H3 200 sm.25.html
static.addtoany.com/menu/ Frame CFDA 0
0 85ms
50ms Document
text/html 172.67.39.148
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://static.addtoany.com/menu/sm.25.html

Requested by

Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js

Protocol

Security

QUIC, , AES_128_GCM

Server

172.67.39.148 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36

Response headers

access-control-allow-origin: *
age: 10830
alt-svc: h3=":443"; ma=86400
cache-control: max-age=315360000, immutable
cf-cache-status: HIT
cf-ray: 8e459ea26e42e523-TXL
content-encoding: br
content-type: text/html; charset=utf-8
date: Mon, 18 Nov 2024 05:39:22 GMT
last-modified: Mon, 18 Nov 2024 02:38:52 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
referrer-policy: strict-origin-when-cross-origin
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=R7xmenuW0E0G98TN24Zu0gAcSXyjdVKPDjjKrHR2TGOpn5iak2tLqD49glu6C9vWFCGJPPAwYgyHiO67PRjodyh4RdHiAC80Nc6dF2E2vINuY8WNN2hdqwDJN5dWM7ALypdpHITE"}],"group":"cf-nel","max_age":604800}
server: cloudflare
speculation-rules: "/cdn-cgi/speculation"
strict-transport-security: max-age=31536000; includeSubDomains; preload
vary: Accept-Encoding
x-content-type-options: nosniff

GET
H3 200 core.m4v434v2.js Show response
static.addtoany.com/menu/modules/ 70 KB
26 KB 81ms
45ms Script
application/javascript 172.67.39.148
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://static.addtoany.com/menu/modules/core.m4v434v2.js

Requested by

Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js

Protocol

Security

QUIC, , AES_128_GCM

Server

172.67.39.148 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

1cd3f28cdd95b9189601f65545a6fc9095734f3bf7d2f74f13e60d86fc86da77

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Origin: https://investors.oricpharma.com
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

content-encoding: br
cf-cache-status: HIT
etag: W/"a4f330a2c6b3bd08f77e32260990108f"
age: 44
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=qbhwwpN4bzI90elhLiVoLKYFf0m5Gic8bMIPubAKyKRT9xLy%2FGt5ArnfolNeQ2JyEdqeHMB6nwZFoo56V2STdN5J6XbShi%2F7u0AnyN4LWOzCuXlS8wPxVx5234PHOok8HlTXALdx"}],"group":"cf-nel","max_age":604800}
x-content-type-options: nosniff
alt-svc: h3=":443"; ma=86400
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: application/javascript
vary: Accept-Encoding
strict-transport-security: max-age=31536000; includeSubDomains; preload
cache-control: max-age=315360000, immutable
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
speculation-rules: "/cdn-cgi/speculation"
referrer-policy: strict-origin-when-cross-origin
cf-ray: 8e459ea26b6ee527-TXL
access-control-allow-origin: *
server: cloudflare

GET
H2 200 ORIC_favicon.png
investors.oricpharma.com/sites/g/files/knoqqb50846/files/ 1 KB
2 KB 45ms
45ms Other
image/png 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL

https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/ORIC_favicon.png

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),

Reverse DNS

Software

Resource Hash

5a8935a6d82bae06fa8d504d3f176d346d4ac8e28cf9b504bc32a4cc121acd3c

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

x-request-id: v-dc0ef0bc-4c4f-11ed-8036-b70fb19758d5
x-content-type-options: nosniff
expires: Mon, 18 Nov 2024 05:48:37 GMT
x-age: 599552
date: Mon, 18 Nov 2024 05:39:22 GMT
content-type: image/png
last-modified: Tue, 21 Apr 2020 14:46:32 GMT
x-cache-hits: 1680
cache-control: max-age=555
x-datastream-cache-status: 3
accept-ranges: bytes
x-datastream-midmile-rtt: 2
content-length: 1488
x-datastream-origin-mex-latency: 92
x-edgeconnect-midmile-rtt: 2, 0, 0, 0, 0, 0, 3
x-edgeconnect-origin-mex-latency: 92, 98, 98, 97, 93, 97, 87

POST
H2 200 pixel_54feafc Show response
investors.oricpharma.com/akam/13/ 0
565 B 44ms
41ms XHR
text/html 2a02:26f0:1700:11::b856:679d
AKAMAI-ASN1 Akama...

General

Check archive.org

Show headers Download Go to

Full URL: https://investors.oricpharma.com/akam/13/pixel_54feafc
Requested by: Host: investors.oricpharma.com
URL: https://investors.oricpharma.com/akam/13/54feafc
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:1700:11::b856:679d Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1 Akamai International B.V., NL),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

User-Agent: Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/130.0.0.0 Safari/537.36
Content-Type: application/x-www-form-urlencoded
Referer: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick

Response headers

date: Mon, 18 Nov 2024 05:39:23 GMT
content-type: text/html
content-length: 0

Verdicts & Comments Add Verdict or Comment

27 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

1 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

			Domain/Path	Expires	Name / Value
			.oricpharma.com/	1970-01-21 01:05:15	Name: ak_bmsc Value: 367A7B7EDD5357AF979C517C5EDF19CC~000000000000000000000000000000~YAAQnWZWuDVy1jqTAQAAEGPIPRm7q21Ri6xtp6oEyNdyQt9oXqGJLihCY2rE5xASlwkpFz+ZxLLbUj9Ag/3aAViYXsaeoJNhjRzAqJ+w9WaJ18OpOujAdTXXn4z8K2+SCeWlTySdYvTm/UdYn3DDeReXg5oLNni/p7PIo8nCdRr9ti1LvUfCv+An370zTBakJJop/Jvp/jfYvsj6JEPlY8m9XtktncMyH2A2yL5OLmXMZveArSNWyST5+B99X0PMb4XLaIgmnF196znBL927VBCsNFhEDv6qEjkO1jbsAeqwEvr8JLAHZGXrHEmC0bGe9rN30FvAR5b3bGUSqyIij1Nm9hfAr0LG0LG0fviPa6UJDkCa6hVgDxbbVFXthkK50J7fdwpbYXva1InZHcSwc1oWcf4CwrnGTHBhZLdipQbrWstK0402q4PVgEItVjcwjT9lVmjpao95BScL5Qor1naDR8oq

10 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
security	warning	Message: Error with Feature-Policy header: Unrecognized feature: 'ambient-light-sensor'.
security	warning	Message: Error with Feature-Policy header: Unrecognized feature: 'speaker'.
security	warning	Message: Error with Feature-Policy header: Unrecognized feature: 'vibrate'.
security	warning	Message: Error with Feature-Policy header: Unrecognized feature: 'vr'.
other	warning	URL: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick Message: Failed to decode downloaded font: https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/fonts/ndqfonticons.woff
other	warning	URL: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick Message: OTS parsing error: incorrect file size in WOFF header
other	warning	URL: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick Message: Failed to decode downloaded font: https://investors.oricpharma.com/sites/g/files/knoqqb50846/themes/site/nir_pid3588/fonts/ndqfonticons.woff
other	warning	URL: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick Message: OTS parsing error: incorrect file size in WOFF header
security	error	URL: https://investors.oricpharma.com/news-releases/news-release-details/oric-pharmaceuticals-announces-multiple-clinical-collaborations?AccountID=13091940&hash=99E2922EEB6FEC86743F5DB2C0E84BA5899D68F68F1472F885291F590EAD713452D3376C362A15DEDE29DFC4761637FD6FDD698F31176C60366847F610D6C32C&utm_source=newsletter&utm_medium=email&utm_campaign=newsletterclick Message: Subresource Integrity: The resource 'https://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js' has an integrity attribute, but the resource requires the request to be CORS enabled to check the integrity, and it is not. The resource has been blocked because the integrity cannot be enforced.
deprecation	error	URL: https://investors.oricpharma.com/sites/g/files/knoqqb50846/files/js/js_UUx8Yq9sCfv_PaPx4x_bEazHLGIMAX9deoZWmyEA-OE.js?scope=footer&delta=3&language=en&theme=nir_pid3588&include=eJyVkFFqAzEMRC8U1h-hkNsI2RaJWFtaZKUlt6_qDQmBFlL84ZnxkxgsbFBWquxqUNHj5EYjPeVBAuloK_kEIDcta-qEAkZFeyeJnFWgXND8Dx4F2204WKByhoz2D3zA7LKz1-bcozGmV3sYMUA9ZRw7-SMmw0VlPKPG-fXdVVsUmuHG9fhxOiX9JDOu-6YvyoOdQNS5xO_8ki33e_KzfdidfLgFq2aChlcplzfAzbR-AxpCpO8(Line 3) Message: Listener added for a 'DOMNodeInserted' mutation event. Support for this event type has been removed, and this event will no longer be fired. See https://chromestatus.com/feature/5083947249172480 for more information.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

assets.adobedtm.com
code.jquery.com
email.analystratings.net
fonts.googleapis.com
fonts.gstatic.com
investors.oricpharma.com
ml.globenewswire.com
stackpath.bootstrapcdn.com
static.addtoany.com
104.18.10.207
142.250.186.99
172.67.39.148
2606:4700:10::6816:296e
2a00:1450:4001:812::200a
2a02:26f0:1700:11::b856:679d
2a02:26f0:3500:587::1e80
2a02:26f0:b700:3::210:cc9d
2a04:4e42::649
022299bc8a5367c7acc5529bd6fd8874f4803263dad42833514fce7cdfa19aa9
09a2967af142f102a1577e8a0831940b3e47101254b9649ee4f64bce68dcf326
12fcd37d1000275e573ddf683e214d16661357a8c36ca0ff45dc349629b6b30e
143e0d65f3b35b3a8c69eee6e94dc27ce2b40ff39968f51f7e08b76b1de63b0c
16b93dd817d794e50af67f1dd4739ba9e23ccb85054fe5e6d7dd7a7e9e7307eb
1cd3f28cdd95b9189601f65545a6fc9095734f3bf7d2f74f13e60d86fc86da77
2aaf0a1ecd155ee00ce4f973bd3874c304aad63a403ffd779c84df1eee8be461
2b4c8c43a52f706e40bc8b247e4a11456fbaaafeafb0a408e6d86d808d1cc4fe
3242a39a60ae61c68fb027c405267374a29a34ca2483031d1f87e6a65cec5d9f
3777c25911c0259e059287354a170a0046dabc074b075d6e5ff47045f7a51492
42736c7de60dfab94b3cc902b8692f80cfeb0a5989d1d51db1d25fd7d18dc45b
430f36f9b5f21aae8cc9dca6a81c4d3d84da5175eaedcf2fdc2c226302cb3575
4c7f9b9700549e0a443d6651062f759fc0743568e0ce58b46306dac9abedb0c4
4d6f6fa0a32e19a1c8fc9e9415bfaaac3554eccfb9c83dd8b54d2fd5aae213c5
4f455eb2ddf2094ee969f470f6bfac7adb4c057e8990a374e9da819e943c777d
4f7fc641a225fff76ef3b4d1ba3fdd12313e81f5820a94aaed71f38e9de331f9
5264c1b1a0919184ed6292af1d92ce7c66e8d8ef788012a7071f02f098b67723
5a8935a6d82bae06fa8d504d3f176d346d4ac8e28cf9b504bc32a4cc121acd3c
5c187131f685db8c505ae2a330d10d1675bc8b8425122dd9fbaef956c507f808
611a6bab4ed69471824f8f2592ac89a2021103bae52a35253c6e09233b2c6e35
642a76ea4d82920a6612f467308daff3ed90bc491f86371eb542641192558336
65f44ffe733bbf9871a7bdd8c430d2b581215f5383fc3ee070ed0f69e41a9da8
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992
71ac5d07c268853b667dce3f9e8c85949a13c88edb6fe1c8327e5d0001262ab7
79c599dd760cec0c1621a1af49d9a2a49da5d45e1b37d4575bace0a5e0226582
80d54533f80e8233621f965ae0a7713928bdb4d491ed0eb5e90434550f1894cb
838b2343c4f8681230419b6df98ebe043a7579d83399fda652fcd51d652fbaaf
88b2eb327407a60a793429c188b5d6b33188c2937a6cefa14bb141673594b963
939fe220ac3999512e38ecd5397d7334210c1568e7aec55eb6c6f4d1316c8353
96a874a36a161a53381e9c5b16dcc188a04da68d463130aaf505c0f08de38782
96acd243fb67175371afbc6e621522128c11cdb95a15d7d707b4ec2c3d84e2cc
976d22490288a04d5bc7edaa827b729f8d7df858b1df77b1aed89675eb2539ca
b7c244a4b0e62a2ca981f44af42a9d6c91bb1fa58586810fe24c0aab6fe44efe
c2427fd8b9f21f0a1f5e72e723ddff2b3f7960058c60d46d8c01736c1d190161
d554361630709572f4c9e33d02ca5ae56275756099a62195513017a0421f73c2
dbf6d86ed58da33f90217f167e9afd12f71c44afe9aa514d8f0aa1499de7396a
e26db4d8e59af5f5c5fb727a2c2bac393b535aad8074be984c1e2e6516dd455f
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
f21bdade54d50ba49de2f0fb872646911bd55d9e614d6dc02389c7042c96f851
fa2c31f1139ecdb4a5ee194df5b10f4844435639cdf791bebae6c49ee5b05089
fdc9964050bfa24c27a3c76c6791b3674292a5f352cbc83d7a4dc49595bc3fb1

investors.oricpharma.com Open in urlscan Pro 2a02:26f0:1700:11::b856:679d Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Page URL History Show full URLs

Detected technologies

Page Statistics

40 Requests

100 %HTTPS

67 %IPv6

9 Domains

9 Subdomains

9 IPs

3 Countries

1481 kBTransfer

4189 kBSize

1 Cookies

27 Outgoing links

Page URL History

Redirected requests

40 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 2 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

investors.oricpharma.com Open in urlscan Pro
2a02:26f0:1700:11::b856:679d Public Scan

Screenshot
Live screenshot

Full Image

40
Requests

100 %
HTTPS

67 %
IPv6

9
Domains

9
Subdomains

9
IPs

3
Countries

1481 kB
Transfer

4189 kB
Size

1
Cookies

40 HTTP transactions
2 data transactions